The consensus analyst price target for AstraZeneca stock has risen slightly from £145.43 to £146.44, reflecting modest ...

Wondering if AstraZeneca’s impressive reputation matches up with its current share price? Let’s take a closer look at what ...

AstraZeneca (NASDAQ: AZN) stock finished the trading week in style, rising by nearly 3% in value on Friday. That was due to ...

AstraZeneca (LSE:AZN) shares have steadily climbed over the past month, up 10% as investors weigh the company’s financial ...

AstraZeneca AZN stock has risen 15% so far this year compared with an increase of 0.2% for the industry. The stock has also outperformed the sector and the S&P 500 index, as seen in the chart below.

AstraZeneca AZN and Merck MRK are both major global pharmaceutical companies with diversified drug portfolios. While Merck is ...

AstraZeneca's price performance YTD exceeds the healthcare sector and broader markets, indicating investors are assuaged regarding concerns across geographies. The company has offered greater clarity ...

The coronavirus vaccine developed by AstraZeneca (NASDAQ: AZN) in partnership with Oxford University has succeeded in preventing transmission of COVID-19. Unfortunately, a disappointing series of ...

AstraZeneca's Baxdrostat cut blood pressure by 14 mmHg in the Phase 3 Bax24 trial, showing strong efficacy and safety in resistant hypertension patients.

AstraZeneca boosts its Harbour BioMed collaboration and invests $2 billion to expand biologics manufacturing and clinical ...